Unknown

Dataset Information

0

Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation.

ABSTRACT: Viral pneumonias in patients with hematologic malignancies and recipients of hematopoietic stem cell transplantation cause significant morbidity and mortality. Advances in diagnostic techniques have enabled rapid identification of respiratory viral pathogens from upper and lower respiratory tract samples. Lymphopenia, myeloablative and T-cell depleting chemotherapy, graft-versus-host disease, and other factors increase the risk of developing life-threatening viral pneumonia. Chest imaging is often nonspecific but may aid in diagnoses. Bronchoscopy with bronchoalveolar lavage is recommended in those at high risk for viral pneumonia who have new infiltrates on chest imaging.

SUBMITTER: Vakil E 

PROVIDER: S-EPMC5373482 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies.
| S-EPMC4789357 | biostudies-literature
Unknown Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection.
| S-EPMC7144878 | biostudies-literature
Unknown Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.
| S-EPMC4935561 | biostudies-literature
Unknown Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.
| S-EPMC4684719 | biostudies-literature
Unknown Respiratory Viral Infections in Solid Organ and Hematopoietic Stem Cell Transplantation.
| S-EPMC7130790 | biostudies-literature
Unknown Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Adult Hematologic Malignancy.
| S-EPMC8627667 | biostudies-literature
Unknown Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.
| S-EPMC3590086 | biostudies-other
Unknown Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients.
| S-EPMC9331161 | biostudies-literature
Clinical Stem Cell Transplantation in Treating Patients With Hematologic Cancer
| 2004049 | ecrin-mdr-crc
Unknown Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.
| S-EPMC6892976 | biostudies-literature